Sunday, October 26, 2025 11:53:11 AM
"So why won’t you acknowledge that this mechanism directly supports the position that DCVax-L is cancer agnostic?"
Yes, I believe dc-vax is designed to be cancer agnostic and may very well be in the future. What I disagree with is that MHRA is taking so long because the application for treatment of glioblastoma is being upgraded to tissue agnostic from the current application.
For everyone, the mechanism is there , the research is there, the science is there. BUT they only applied for treatment of glioblastoma with the MHRA. How difficult is that to understand? You are claiming "the scope of the language" while I am standing by what she actually said. If you want to talk about reality, I am here. But I'm tired of arguing against the pumpers. Here is my standard reply from now on. I hope this helps with their delusion.
You're absolutely right. We will be approved for tissue agnostic worth billions, we will have a short squeeze worth billions, and lawsuit will net us billions
Yes, I believe dc-vax is designed to be cancer agnostic and may very well be in the future. What I disagree with is that MHRA is taking so long because the application for treatment of glioblastoma is being upgraded to tissue agnostic from the current application.
For everyone, the mechanism is there , the research is there, the science is there. BUT they only applied for treatment of glioblastoma with the MHRA. How difficult is that to understand? You are claiming "the scope of the language" while I am standing by what she actually said. If you want to talk about reality, I am here. But I'm tired of arguing against the pumpers. Here is my standard reply from now on. I hope this helps with their delusion.
You're absolutely right. We will be approved for tissue agnostic worth billions, we will have a short squeeze worth billions, and lawsuit will net us billions
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
